Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Semaphorin 3A for treatment and assessment of severity of Asthma

Semaphorin 3A for treatment and assessment of severity of Asthma

US Patent 10568932 · Granted Feb 25, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Semaphorin 3A for treatment and assessment of severity of inflammatory bowel dis2020
Semaphorin 3A for treatment and assessment of severity of inflammatory bowel dis2020
Semaphorin 3A as a diagnostic marker for urothelial cancer2018
Semaphorin 3A as a diagnostic marker for urothelial cancer2018
Semaphorin 3A for treatment of systemic lupus erythematosus2018
Semaphorin 3A for treatment of systemic lupus erythematosus2018
Pharmaceutical compositions and methods useful for modulating angiogenesis, inhi2014
Methods and compositions for modulating angiogenesis2012
Method for assessing metastatic properties of breast cancer2012